price
EB
NASDAQ · EBS
Emergent BioSolutions Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$7.02
Down-$0.05 (-0.64%)
Updated Sep 18, 2026, 1:43 PM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 633.13M
- P/E ratio
- 8.22
- Dividend yield
- 0.00%
- 52-week range
- $4.36 – $9.66
- Volume
- 1.38M
- Avg. volume
- 1.09M
Price performance
EBS price history
1M range · 20 trading sessions · Daily adjusted prices
EBS closed at $7.02 after 20 trading sessions, up 45.64% for the selected period.
- Last close
- $7.02
- Period change
- +45.64%
- Period low
- $4.82
- Period high
- $7.02
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $6.84 | $7.05 | $6.795 | $7.02 | 1.38M |
| Sep 16, 2026 | $6.40 | $6.80 | $6.39 | $6.75 | 1.61M |
| Sep 15, 2026 | $6.36 | $6.47 | $6.23 | $6.36 | 1.02M |
| Sep 14, 2026 | $6.21 | $6.50 | $6.175 | $6.38 | 685.15K |
| Sep 11, 2026 | $5.98 | $6.39 | $5.875 | $6.23 | 1.3M |
| Sep 10, 2026 | $5.59 | $5.99 | $5.50 | $5.87 | 2.39M |
| Sep 9, 2026 | $5.96 | $6.04 | $5.605 | $5.68 | 1.17M |
| Sep 8, 2026 | $6.15 | $6.15 | $5.96 | $6.00 | 703.24K |
| Sep 4, 2026 | $6.26 | $6.30 | $6.14 | $6.21 | 998.57K |
| Sep 3, 2026 | $6.56 | $6.60 | $5.97 | $6.23 | 1.1M |
| Sep 2, 2026 | $6.23 | $6.50 | $6.23 | $6.46 | 1.03M |
| Sep 1, 2026 | $6.16 | $6.285 | $5.995 | $6.22 | 972.44K |
| Aug 31, 2026 | $5.88 | $6.115 | $5.80 | $6.10 | 1.13M |
| Aug 28, 2026 | $5.96 | $6.11 | $5.88 | $5.91 | 1.24M |
| Aug 27, 2026 | $5.98 | $6.005 | $5.75 | $5.94 | 1.3M |
| Aug 26, 2026 | $5.56 | $6.00 | $5.55 | $5.97 | 1.17M |
| Aug 25, 2026 | $5.20 | $5.67 | $5.20 | $5.64 | 1.36M |
| Aug 24, 2026 | $5.02 | $5.22 | $5.00 | $5.18 | 871.18K |
| Aug 21, 2026 | $4.79 | $5.105 | $4.75 | $5.08 | 1.42M |
| Aug 20, 2026 | $4.88 | $4.935 | $4.58 | $4.82 | 1.51M |
Latest EBS news
The latest Smart Investors Daily articles mentioning EBS.
Stock researchCompany · Financials
Loading stock research…